Search Results 1041-1050 of 16987 for pharmacogenetics
Park SJ, Kim M, Jeong S, Choi S, Park YJ, Kim HJ, Song J, Lee J, Choi J, Lee JW, Jeong J, Yu J, Chang J, Oh YH, Ahn JC, Park SM.
Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment- ...
Cortez GM, Monteiro A, Ludwig B, Hanel R. Reappraisal of haemorrhagic suprasellar pilocytic astrocytoma during adulthood. BMJ Case Rep. 2020 Oct 29; 13 (10)
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The purpose of the INOVATE-HF study is to demonstrate the long-term safety and efficacy of vagus nerve stimulation with the CardioFit system for the treatment ...
This study aims to measure the effects of biophilic visual features and acoustic features on office worker's mood and connectedness to nature, stress levels, ...
As a pulmonologist and genomic scientist, Victor Ortega, M.D., Ph.D., is leading a charge to breathe new life into precision medicine advancements. His mission ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...
Gene transfer provides a strategy for overcoming this limitation. It is based upon the hypothesis that the delivery of genes, or their complementary DNAs (cDNAs) ...
Rochester, Minn. The aim of this study is to develop a feasible, acceptable, and sustainable comprehensive cancer distress management program that is tailored ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.